Emergent Medical Partners, the venture capital shop led by medical device legend Dr. Thomas Fogarty, raised $37 million from 4 unnamed investors, according to a regulatory filing.
Emergent invests in early-stage medical device outfits, which are often the brainchild of physicians or engineers that Emergent helps develop, according to its website.
Fogarty, a cardiovascular surgeon, is renowned in medical device circles for inventing the "industry standard" Fogarty balloon embolectomy catheter (acquired by Edwards Lifesciences (NYSE:EW)), and the Aneurx stent graft (acquired by Medtronic (NYSE:MDT)), as well as for his serial entrepreneurship.
He’s served as founder or co-founder and chairman or director of more than 30 medical device companies, according to the Emergent site, "the majority based on devices designed and developed by Fogarty Engineering Inc."
Emergent’s portfolio includes some 30 medical device and life science enterprises, including Ardian (acquired for $800 million by Medtronic in 2010) and Reverse Medical, which landed 510(k) clearance from the FDA for its MVP micro vascular plug last month.